RACHEL CHOATE: Open Payments
NPI 1962862557 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 18 payments from 9 companies in 2025. Trend: 2023 $848 · 2024 $683 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $75 |
| UCB, Inc. | 3 | $66 |
| Janssen Biotech, Inc. | 4 | $66 |
| Kerecis Limited | 2 | $41 |
| LEO Pharma Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $22 |
| GENZYME CORPORATION | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: Bimzelx, TREMFYA, Kerecis SurgiClose, BLU-U, ILUMYA, ANZUPGO, RINVOQ, DUPIXENT.
Industry payments across AR — which companies pay providers there.
